Financial & Investor
Information

• About Us
  • Mission & Company Strategy
  • Management Team
  • Governance & Compliance
    • Vermont Prescribers Information
    • California Declaration of Compliance
  • Gastroenterologist Marketplace
  • Contact Us/Locations
• Products
  • COLAZAL
  • XIFAXAN
  • MOVIPREP
  • OSMOPREP
  • VISICOL
  • AZASAN
  • ANUSOL/PROCTOCORT
  • DIURIL
  • PEPCID
  • Prescribing Information
• Gastro Resource Center
  • Patient Resources
    • Web Resources
    • Patient Newsletters
    • Colon Cancer Facts
  • Physician Resources
    • CME Links
    • Web Links
    • Info for Your Patients
    • Meeting Info
    • Request Information
  • Pharmacist Information
    • Product Ordering
    • Continuing Education
    • Medicare Part D
    • Reimbursement Info
  • Request a Grant
    • About Grants
    • Submission Requirements
    • Request Forms
    • Contact
• Research & Development
• Financial & Investors
  • Financial Reports
  • Stockholder Services
  • Analyst Information
  • Investor Relations Kit
  • Financial Presentations
  • Request Email Updates
• Partnership & Licensing
• News Room
  • Media Kits
• Careers

Detailed Stock Quote

Salix Financial Report & Investment Opportunities

In this section you can view the most recent Salix press releases, SEC filings, including 10-K and 10-Q filings, get a current stock quote and find annual reports. You may also request to receive news by e-mail as well as have corporate materials mailed to you.

Click on a link for further information:

• Financial Reports
• Stockholder Services
• Investor Relations Kit
• Financial Presentations
• Request Email Updates

We hope you find this section helpful as you research Salix. If you do not find what you are looking for, or require additional assistance, please contact Investor Relations:

G. Michael Freeman
Associate Vice President, Investor Relations & Corporate Communications

Phone: 919-862-1000

E-Mail: